Dan Marquess serves as Executive at Unity Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Dan Marquess has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 22, 2020 involved selling 2,483 shares valued at $24.0K.
Dan Marquess currently holds 380,690 shares of Unity Biotechnology, Inc. (UBX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dan Marquess has been a net neutral trader of UBX stock. They have purchased $0 and sold $0 worth of shares.
Dan Marquess's most recent insider trade was on Jun 22, 2020, when they sold 2,483 shares at $9.67 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 20, 2019 | UBX | $0 | Award | 21,075 | $N/A | Discretionary |